Showing results (1-10 of 216) with videos related to
Sort By:
Pageof 22
Frontiers in Medicine|December 23, 2017
Innovative Approaches to Increase Access to Medicines in Developing CountriesHilde Stevens, Isabelle HuysDrug Discovery Today|November 26, 2020
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutionsEline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.Frontiers in Medicine|October 27, 2018
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and PracticeRosanne Janssens, Eline van Overbeeke, Lotte Verswijvel, et al.Frontiers in Medicine|November 12, 2021
R&D Costs of New Medicines: A Landscape AnalysisSteven Simoens, Isabelle HuysPharmaceuticals (Basel, Switzerland)|May 28, 2022
Emerging Insights into European Markets of Biologics, Including BiosimilarsSteven Simoens, Isabelle HuysThe European Journal of Neuroscience|May 20, 2003
Evidence for a function-specific mutation in the neurotoxin, parabutoxin 3Isabelle Huys, Jan TytgatDrug Discovery Today|December 5, 2021
How much do the public sector and the private sector contribute to biopharmaceutical R&D?Steven Simoens, Isabelle HuysSeminars in Thrombosis and Hemostasis|December 14, 2012
Market entry of biosimilar low-molecular-weight heparins in Europe: opportunities and challengesSteven Simoens, Isabelle HuysTrials|May 5, 2021
Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchCiska Verbaanderd, Ilse Rooman, Isabelle HuysJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 18, 2004
Structure-function study of a chlorotoxin-chimer and its activity on Kv1.3 channelsIsabelle Huys, Etienne Waelkens, Jan TytgatPageof 22